Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences

Biochimie

Volumn 96, Issue 1, 2014, Pages 121-129

  Hijmans, Brenda S ^a   Grefhorst, Aldo ^b   Oosterveer, Maaike H ^a   Groen, Albert K ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Insulin signaling paradox; Metabolic syndrome; Metabolic zonation; Non alcoholic fatty liver disease

Indexed keywords

BETA CATENIN; FATTY ACID; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; WNT PROTEIN;

CONCEPTUAL FRAMEWORK; FATTY ACID METABOLISM; FATTY LIVER; GENETIC MODEL; GLUCOSE METABOLISM; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOGENESIS; LIVER METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; ONCOGENE H RAS; REVIEW; STEATOSIS; WNT SIGNALING PATHWAY;

INSULIN SIGNALING PARADOX; METABOLIC SYNDROME; METABOLIC ZONATION; NON-ALCOHOLIC FATTY LIVER DISEASE;

ANIMALS; FATTY ACIDS; FATTY LIVER; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 84890568045     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.06.007     Document Type: Review

References (115)

1. L.S. Beale Minute anatomy of the liver Am. J. Med. Sci. 64 1856 469
2. K. Jungermann Heterogeneity of liver parenchymal cells Trends Biochem. Sci. 3 1978 198
3. A.M. Rappaport The structural and functional unit in the human liver (liver-acinus) Anat. Rec. 130 1958 673 689
4. W.H. Lamers, A. Hilberts, and E. Furt Hepatic enzymic zonation - a reevaluation of the concept of the liver acinus Hepatology 10 1989 72 76
5. R. Gebhardt Metabolic zonation of the liver - regulation and implications for liver-function Pharmacol. Ther. 53 1992 275 354
6. N.R. Katz Metabolic heterogeneity of hepatocytes across the liver acinus J. Nutr. 122 1992 843 849
7. M. Guzman, and J. Castro Zonation of fatty-acid metabolism in rat-liver Biochem. J. 264 1989 107 113
8. K. Jungermann, and R.G. Thurman Hepatocyte heterogeneity in the metabolism of carbohydrates Enzyme 46 1992 33 58
9. B. Quistorff, N. Katz, and L.A. Witters Hepatocyte heterogeneity in the metabolism of fatty acids: discrepancies on zonation of acetyl-CoA carboxylase Enzyme 46 1992 59 71
10. K. Jungermann, and T. Kietzmann Zonation of parenchymal and nonparenchymal metabolism in liver Annu. Rev. Nutr. 16 1996 179 203
11. W.H. Lamers, K.E. Hoynes, D. Zonneveld, A.F. Moorman, and R. Charles Noradrenergic innervation of developing rat and spiny mouse liver. Its relation to the development of the liver architecture and enzymic zonation Anat. Embryol. (Berl) 178 1988 175 181
12. R. Gebhardt, and F. Gaunitz Cell-cell interactions in the regulation of the expression of hepatic enzymes Cell Biol. Toxicol. 13 1997 263 273
13. A.F. Moorman, P.A. de Boer, R. Charles, and W.H. Lamers Diet- and hormone-induced reversal of the carbamoylphosphate synthetase mRNA gradient in the rat liver lobulus FEBS Lett. 276 1990 9 13
14. R. Gebhardt, and D. Mecke Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture EMBO J. 2 1983 567 570
15. S. Colnot, T. Decaens, and M. Niwa-Kawakita Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas Proc. Natl. Acad. Sci. U. S. A. 101 2004 17216 17221
16. S. Hailfinger, M. Jaworski, A. Braeuning, A. Buchmann, and M. Schwarz Zonal gene expression in murine liver: lessons from tumors Hepatology 43 2006 407 414
17. S. Benhamouche, T. Decaens, and C. Godard Apc tumor suppressor gene is the "zonation-keeper" of mouse liver Dev. Cell. 10 2006 759 770
18. A. Moriyama, I. Kii, and T. Sunabori GFP transgenic mice reveal active canonical Wnt signal in neonatal brain and in adult liver and spleen Genesis 45 2007 90 100
19. M. Colletti, C. Cicchini, and A. Conigliaro Convergence of Wnt signaling on the HNF4 alpha-driven transcription in controlling liver zonation Gastroenterology 137 2009 660 672
20. A. Braeuning, C. Ittrich, C. Koehle, A. Buchmann, and M. Schwarz Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas Drug Metab. Dispos. 35 2007 503 507
21. H. Hvid, J. Fels, and R. Kirk In situ phosphorylation of Akt and ERK1/2 in rat mammary gland, colon, and liver following treatment with human insulin and IGF-1 Toxicol. Pathol. 39 2011 623 640
22. A. Braeuning, M. Menzel, and E. Kleinschnitz Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes FEBS J. 274 2007 4766 4777
23. D. Odom, N. Zizlsperger, and D.B. Gordon Control of pancreas and liver gene expression by HNF transcription factors Science 303 2004 1378 1381
24. K.O. Lindros, T. Oinonen, J. Issakainen, P. Nagy, and S.S. Thorgeirsson Zonal distribution of transcripts of four hepatic transcription factors in the mature rat liver Cell Biol. Toxicol. 13 1997 257 262
25. V.S. Stanulovic, I. Kyrmizi, and M. Kruithof-de Julio Hepatic HNF4 alpha deficiency induces periportal expression of glutamine synthetase and other pericentral enzymes Hepatology 45 2007 433 444
26. D. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
27. S. Yekta, I.H. Shih, and D.P. Bartel MicroRNA-directed cleavage of HOXB8 mRNA Science 304 2004 594
28. S. Sekine, R. Ogawa, M.T. Mcmanus, Y. Kanai, and M. Hebrok Dicer is required for proper liver zonation J. Pathol. 219 2009 365 372
29. R. Friedman, K. Farh, C. Burge, and D. Bartel Most mammalian mRNAs are conserved targets of microRNAs Genome Res. 19 2009 92 105
30. J. Radziuk, and S. Pye Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis Diabetes Metab. Res. Rev. 17 2001 250 272
31. K. Jungermann Dynamics of zonal hepatocyte heterogeneity. Perinatal development and adaptive alterations during regeneration after partial hepatectomy, starvation and diabetes Acta Histochem. Suppl. 32 1986 89 98
32. K. Jungermann Metabolic zonation of liver parenchyma: significance for the regulation of glycogen metabolism, gluconeogenesis, and glycolysis Diabetes Metab. 3 1987 269 293
33. K. Jungermann, and T. Kietzmann Role of oxygen in the zonation of carbohydrate metabolism and gene expression in liver Kidney Int. 51 1997 402 412
34. C.G. Jones, and M.A. Titheradge Measurement of metabolic fluxes through pyruvate kinase, phosphoenolpyruvate carboxykinase, pyruvate dehydrogenase, and pyruvate carboxylase in hepatocytes of different acinar origin Arch. Biochem. Biophys. 326 1996 202
35. K.S. Chen Zonation of glycogen and glucose syntheses, but not glycolysis, in rat liver Biochem. J. 255 1988 99
36. D. Wölfle, H. Schmidt, and K. Jungermann Short-term modulation of glycogen metabolism, glycolysis and gluconeogenesis by physiological oxygen concentrations in hepatocyte cultures Eur. J. Biochem. 135 1983 405
37. H. Bartels, B. Vogt, and K. Jungermann Glycogen synthesis from pyruvate in the periportal and from glucose in the perivenous zone in perfused livers from fasted rats FEBS Lett. 221 1987 277 283
38. A. Chocarro Calvo, J.M. García-Martínez, S. Ardila-González, A. De la Vieja, and C. García-Jiménez Glucose-induced ß-catenin acetylation enhances Wnt signaling in cancer Mol. Cell. 49 2013 474 486
39. D. Sasse Dynamics of liver glycogen: the topochemistry of glycogen synthesis, glycogen content and glycogenolysis under the experimental conditions of glycogen accumulation and depletion Histochemistry 45 1975 237 254
40. K.O. Lindros, and K.E. Penttila Digitonin-collagenase perfusion for efficient separation of periportal or perivenous hepatocytes Biochem. J. 228 1985 757 760
41. B. Quistorff Gluconeogenesis in periportal and perivenous hepatocytes of rat liver, isolated by a new high-yield digitonin/collagenase perfusion technique Biochem. J. 229 1985 221 226
42. N.R. Katz, W. Fischer, and S. Giffhorn Distribution of enzymes of fatty-acid and ketone-body metabolism in periportal and perivenous rat-liver tissue Eur. J. Biochem. 135 1983 103 107
43. M. Guzman, C. Bijleveld, and M.J.H. Geelen Flexibility of zonation of fatty-acid oxidation in rat-liver Biochem. J. 311 1995 853 860
44. N.M. Bass, M.E. Barker, J.A. Manning, A.L. Jones, and R.K. Ockner Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate-treated rats Hepatology 9 1989 12 21
45. T. Suzuki, and T. Ono Immunohistochemical studies on the distribution and frequency of fatty-acid-binding protein positive cells in human fetal, newborn and adult liver tissues J. Pathol. 153 1987 385 394
46. N.M. Bass Fatty acid-binding protein expression in the liver: its regulation and relationship to the zonation of fatty acid metabolism Mol. Cell. Biochem. 98 1990 167 176
47. J.G. Fitz Hepatic transport of a fluorescent stearate derivative: electrochemical driving forces in intact rat liver Am. J. Physiol. Gastrointest. Liver Physiol. 261 1991 G83
48. H. Miethke, B. Wittig, A. Nath, S. Zierz, and K. Jungermann Metabolic zonation in liver of diabetic rats - zonal distribution of phosphoenolpyruvate carboxykinase, pyruvate-kinase, glucose-6-phosphatase and succinate- dehydrogenase Biol. Chem. Hoppe-Seyler 366 1985 493 501
49. S.P. Burns, R.D. Cohen, and R.A. Iles Zonation of gluconeogenesis, ketogenesis and intracellular pH in livers from normal and diabetic ketoacidotic rats: evidence for intralobular redistribution of metabolic events in ketoacidosis Biochem. J. 343 Pt 1 1999 273 280
50. M. Guzman, and J. Castro Zonal heterogeneity of the effects of chronic ethanol feeding on hepatic fatty acid metabolism Hepatology 12 1990 1098 1105
51. P. Tessari, A. Coracina, A. Cosma, and A. Tiengo Hepatic lipid metabolism and non-alcoholic fatty liver disease Nutr. Metab. Cardiovasc. Dis. 19 2009 291 302
52. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, and E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J. Clin. Invest. 115 2005 1343 1351
53. M. Timlin, and E. Parks Temporal pattern of de novo lipogenesis in the postprandial state in healthy men Am. J. Clin. Nutr. 81 2005 35 42
54. J. Schwarz, P. Linfoot, D. Dare, and K. Aghajanian Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets Am. J. Clin. Nutr. 77 2003 43 50
55. M. Kohjima, M. Enjoji, and N. Higuchi Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease Int. J. Mol. Med. 20 2007 351
56. L. Zhu, S. Baker, and W. Liu Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis Metab. Clin. Exp. 60 2011 1001 1011
57. A.J. Sanyal, C. Campbell Sargent, and F. Mirshahi Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
58. E. Fabbrini, B.S. Mohammed, F. Magkos, K. Korenblat, B. Patterson, and S. Klein Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease Gastroenterology 134 2008 424 431
59. E.M. Brunt Pathology of fatty liver disease Mod. Pathol. 20 Suppl. 1 2007 S40 S48
60. N. Chalasani, L. Wilson, and D.E. Kleiner Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease J. Hepatol. 48 2008 829 834
61. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J. Hepatol. 37 2002 56 62
62. G.A. MacDonald, K.R. Bridle, and P.J. Ward Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3 J. Gastroenterol. Hepatol. 16 2001 599 606
63. S. Shaw Lipid peroxidation, iron mobilization and radical generation induced by alcohol Free Radic. Biol. Med. 7 1989 541 547
64. D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
65. C. Carter Kent, E. Brunt, and L. Yerian Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease J. Pediatr. Gastroenterol. Nutr. 52 2011 190 197
66. E.M. Brunt, and D.G. Tiniakos Fatty liver disease R.D. Odze, J.R. Goldblum, Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas second ed. 2009 Saunders Elsevier 1112
67. L.A. Campfield, F.J. Smith, and P. Burn The OB protein (leptin) pathway-a link between adipose tissue mass and central neural networks Horm. Metab. Res. 28 1996 619 632
68. G.H. Lee, R. Proenca, and J.M. Montez Abnormal splicing of the leptin receptor in diabetic mice Nature 379 1996 632 635
69. Y. Lee, M.Y. Wang, and T. Kakuma Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia J. Biol. Chem. 276 2001 5629 5635
70. C.H. Wiegman, R.H.J. Bandsma, and M. Ouwens Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin Diabetes 52 2003 1081 1089
71. R.J.R. Flach, H. Qin, L. Zhang, and A. Bennett Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor a (DFFA)-like effector C (CIDEC)/fat-specific protein 27 J. Biol. Chem. 286 2011 22195 22202
72. S. Collins, T. Martin, R. Surwit, and J. Robidoux Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics Physiol. Behav. 81 2004 243 248
73. M.J.S. Frederico Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice Scand. J. Gastroenterol. 46 2011 1381 1388
74. N. Lanthier Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet FASEB J. 25 2011 4301
75. Z. Sun, R. Miller, and R. Patel Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration Nat. Med. 18 2012 934 942
76. I.C. Gaemers, J.M. Stallen, and C. Kunne Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease Biochim. Biophys. Acta Mol. Basis Dis. 1812 2011 447 458
77. M. Dekker, Q. Su, C. Baker, A. Rutledge, and K. Adeli Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome Am. J. Physiol. Endocrinol. Metab. 299 2010 E685 E694
78. R. Buettner, K.G. Parhofer, and M. Woenckhaus Defining high-fat-diet rat models: metabolic and molecular effects of different fat types J. Mol. Endocrinol. 36 2006 485 501
79. B.R. Bacon, C.H. Park, E.M. Fowell, and C.E. Mclaren Hepatic steatosis in rats fed diets with varying concentrations of sucrose Fundam. Appl. Toxicol. 4 1984 819 826
80. L.H. Tetri, M. Basaranoglu, E.M. Brunt, L.M. Yerian, and B.A. Neuschwander-Tetri Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent Am. J. Physiol. Gastrointest. Liver Physiol. 295 2008 G987 G995
81. F.A. Hommes Inborn errors of fructose metabolism Am. J. Clin. Nutr. 58 1993 788S 795S
82. A. Asipu, B.E. Hayward, J. O'Reilly, and D.T. Bonthron Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria Diabetes 52 2003 2426
83. C.P. Diggle, M. Shires, and D. Leitch Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme J. Histochem. Cytochem. 57 2009 763
84. H. Cortez-Pinto, J. Chatham, V. Chacko, C. Arnold, A. Rashid, and A.M. Diehl Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis J. Am. Med. Assoc. 282 1999 1659 1664
85. P.A. Mayes Intermediary metabolism of fructose Am. J. Clin. Nutr. 58 1993 754S 765S
86. K.L. Stanhope, J.M. Schwarz, and N.L. Keim Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans J. Clin. Invest. 119 2009 1322
87. S.P. Burns, H.C. Murphy, R.A. Iles, R.A. Bailey, and R.D. Cohen Hepatic intralobular mapping of fructose metabolism in the rat liver Biochem. J. 349 2000 539 545
88. P. Almeda-Valdes, D. Cuevas-Ramos, and C.A. Aguilar-Salinas Metabolic syndrome and non-alcoholic fatty liver disease Ann. Hepatol. 8 Suppl. 1 2009 S18 S24
89. J. Manchanayake, S. Chitturi, C. Nolan, and G.C. Farrell Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease J. Gastroenterol. Hepatol. 26 2011 510 516
90. J. Browning, L. Szczepaniak, and R. Dobbins Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
91. A. Grefhorst, J. Hoekstra, and T.G. Derks Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production Am. J. Physiol. Gastrointest. Liver Physiol. 289 2005 G592 G598
92. R.H.J. Bandsma, B.H. Prinsen, and Monique De Sain Van Der Velden Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1 Pediatr. Res. 63 2008 702 707
93. S.B. Biddinger, A. Hernandez-Ono, and C. Rask-Madsen Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis Cell Metab. 7 2008 125 134
94. A. Grefhorst, T. van Dijk, and A. Hammer Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice Am. J. Physiol. Endocrinol. Metab. 289 2005 E829 E838
95. Z. Sun, and M. Lazar Dissociating fatty liver and diabetes Trends Endocrinol. Metab. 24 2013 4
96. A. Bracht, J. Constantin, E.L. Ishii-Iwamoto, and F. Suzuki-Kemmelmeier Zonation of gluconeogenesis from lactate and pyruvate in the rat liver studied by means of anterograde and retrograde bivascular perfusion Biochim. Biophys. Acta 1199 1994 298 304
97. I. Shimomura, M. Matsuda, R.E. Hammer, Y. Bashmakov, M.S. Brown, and J.L. Goldstein Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice Mol. Cell. 6 2000 77 86
98. M. Brown, and J. Goldstein Selective versus total insulin resistance: a pathogenic paradox Cell Metab. 7 2008 95 96
99. M.S. Brown, and J.L. Goldstein The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340
100. R.A. Haeusler, and D. Accili The double life of Irs Cell Metab. 8 2008 7 9
101. X.C. Dong, K.D. Copps, and S. Guo Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation Cell Metab. 8 2008 65 76
102. N. Kubota, T. Kubota, and S. Itoh Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding Cell Metab. 8 2008 49 64
103. S. Li, M. Brown, and J. Goldstein Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis Proc. Natl. Acad. Sci. U. S. A. 107 2010 3441 3446
104. C. Taniguchi, T. Kondo, and M. Sajan Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta Cell Metab. 3 2006 343 353
105. X. Wu NOX4 pathway as a source of selective insulin resistance and responsiveness Arterioscler. Thromb. Vasc. Biol. 32 2012 1236
106. C.M. Taniguchi, B. Emanuelli, and C.R. Kahn Critical nodes in signalling pathways: insights into insulin action Nat. Rev. Mol. Cell Biol. 7 2006 85 96
107. M.D. Michael, R.N. Kulkarni, and C. Postic Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction Mol. Cell. 6 2000 87 97
108. J.L. Yecies, H.H. Zhang, and S. Menon Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways Cell Metab. 14 2011 21
109. S. Patil, B. Chauhan, and S. Guo FoxO1 regulates multiple metabolic pathways in the liver J. Biol. Chem. 281 2006 10105
110. N.A. Bourbon, J. Yun, and M. Kester Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex J. Biol. Chem. 275 2000 35617 35623
111. T. Fox, K. Houck, and S. O'Neill Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains J. Biol. Chem. 282 2007 12450 12457
112. E. Hajduch, S. Turban, and X. Le Liepvre Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide Biochem. J. 410 2008 369 379
113. M. Salinas, R. López Valdaliso, D. Martín, A. Alvarez, and A. Cuadrado Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells Mol. Cell. Neurosci. 15 2000 156 169
114. J. Chavez, T. Knotts, and L. Wang A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids J. Biol. Chem. 278 2003 10297 10303
115. P. Bell, L. Wang, and G. Gao Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primates Mol. Genet. Metab. 104 2011 395 403